baber/WOPTO huggingface dataset:
Patent FI-963494-A0 (FI)
Inventor: LEINONEN ANTTI
IPC: D21F1/48
Filed: 1996-09-06
Abstract: PCT No. PCT/FI97/00487 Sec. 371 Date May 4, 1998 Sec. 102(e) Date May 4, 1998 PCT Filed Aug. 22, 1997 PCT Pub. No. WO98/10138 PCT Pub. Date Mar. 12, 1998The invention relates to a method for preventing rewetting of a web in a former. Water is removed from the web (W) by means of dewatering members. The web (W) is formed by forming members and forming rolls on support of a wire loop/loops. The wire loop/loops (10) is/are guided by alignment, guide and/or suction rolls (11, 12). The web (W) supported by a wire (10) is passed by at least two vacuum boxes/chambers (16, 17) after the last suction roll (11). At least two vacuum boxes/chambers (16, 17) are fitted after the last suction roll (11). The web (W) and the wire (10) are arranged to be dewatered by means of a first vacuum box/chamber (16). The transport of moisture from the wire (10) back into the web (W) is prevented by means of a second vacuum box/chamber (17), and a vacuum (P1) in the first vacuum box/chamber (16) is higher than a vacuum (P2) in the second vacuum box/chamber (17).
Patent FI-963665-A0 (FI)
Inventor: WIDLUND URBAN
IPC: A41B13/00
Filed: 1996-09-17
Abstract: An absorbent article having a front part (12), a rear part (14) and an intermediate crotch part (13), such as a diaper, an incontinence guard or like article. The article includes an absorbent body (1), a liquid-impermeable bottom sheet (7) joined to the absorbent body, and a top sheet (9) which is free from connection with the absorbent body over a large part of its surface and which lies proximal to the wearer's body when the article is worn, and which top sheet includes an opening (15) which extends from the rear article part into the crotch part, and elastic devices (24, 25) which are fastened to the top sheet in a stretched state and which when contracting from the stretched state cause the part of the top sheet that is not joined to the absorbent body to be distanced from the body. The top sheet (9) includes a further opening (16) which extends from the front part (12) into the crotch part (13). A piece (26) of flexible material extends transversely across the article between the absorbent body (1) and the top sheet (9) within that region of the top sheet that lies between the two openings (15, 16), this piece of flexible material being fastened to the absorbent body and to the top sheet.
Patent FI-964781-A0 (FI)
Inventor: METZ JR WILLIAM ARTHUR
IPC: C07K5/103
Filed: 1996-11-29
Abstract: This invention relates to compounds which are inhibitors of elastase, particularly human neutrophil elastase. The inhibitors are short, synthetic peptides in which the P2 moiety is substituted with various nitrogen-containing heterocyclic groups. As inhibitors of human neutrophil elastase, the compounds are useful in the treatment of a patient afflicted with a neutrophil associated inflammatory disease.
Patent FI-991283-A0 (FI)
Inventor: EINOLA HEIKKI
IPC: H04W12/06
Filed: 1999-06-04
Abstract: A method of arranging data protection in a telecommunication system including a first mobile communication network, a second mobile communication network, and a mobile station supporting both of the mobile communication networks is disclosed. The method includes ciphering traffic between the mobile station and the first mobile communication network using a first cipher key; calculating a second cipher key to be used for ciphering traffic between the mobile station and the second mobile communication network in the first mobile communication network when the mobile station operates in the first mobile communication network; transmitting information necessary for calculating the second cipher key from the first mobile communication network to the mobile station when the mobile station operates in the first mobile communication network; and calculating the second cipher key at the mobile station to be used for ciphering traffic between the mobile station and the second mobile communication network.
Patent IL-62332-A0 (IL)
Title: 1,1-diphenyl-2-(1,2,4-triazol-1-yl)-ethan-1-ols,their preparation and pharmaceutical compositions containing them
IPC: A61K31/41
Filed: 1981-03-09
Abstract: 1. A 1,1-diphenyl-2-(1,2,4-triazol-1-1-yl)-ethanol of the general formula I  see diagramm : EP0036153,P8,F1  where one of the radicals R**1, R**2 and R**3 is chlorine and the others, which may be identical or different, are hydrogen or chlorine, and its pharmacologically tolerated salts as antimycotics.
Patent IL-86862-A0 (IL)
Title: Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
IPC: A61K38/21
Filed: 1988-06-26
Abstract: The use of a double-stranded RNA for the manufacture of a medicament for treating an inflammatory disorder characterised by elevated levels of circulating immune complexes in the patient's blood.
Patent IL-86893-A0 (IL)
Title: Ab-006 antibiotics,their production and their use as fungicides and insecticides
IPC: A01N63/28
Filed: 1988-06-28
Abstract: AB-006 Antibiotics and their AB-006a and AB-006b Antibiotic components, obtained by controlled aerobic culture of Streptomyces s.p. NCIB 12425, in an aqueous nutrient culture medium. The AB-006 Antibiotics show biological activity, and in particular fungicidal and insecticidal activity.
Patent IL-97638-A0 (IL)
Title: Multi-functional pharmaceutical compositions and methods of use
IPC: C07D473/30
Filed: 1991-03-21
Abstract: Novel bi-functional pharmaceutical compounds, particularly novel 9-substituted hypoxanthines of the general formula:  <IMAGE>  where R is a neurologically active moiety, are described as pharmaceutical agents for treating neuroimmunologic disorders in mammals. Novel methods for the utilization of these compounds are also disclosed. These compounds exhibit uniquely dose-dependent, synergistic biological properties and are particularly useful for treating interrelated physiological systems.
Patent FI-20095197-A0 (FI)
Inventor: VALLIUS TUOMAS
Filed: 2009-02-27
Abstract: An image display device having an RGB illuminating module that includes a diffractive beam combiner. The diffractive beam combiner includes a first light source arranged to provide a first light beam having red color and a second light source arranged to provide a second light beam having green color. A centerline of the first light beam and a centerline of the second light beam are arranged to intersect at an intersection point. A diffractive output grating is located in the vicinity of the intersection point. The diffractive output grating is arranged to form an output light beam by diffracting light of the first light beam and light of the second light beam substantially in the same direction.
Patent IL-100476-A0 (IL)
Title: Amines,processes for the preparation thereof and pharmaceutical compositions containing them
IPC: C07C311/13
Filed: 1991-12-23
Abstract: PCT No. PCT/EP91/02456 Sec. 371 Date Jun. 21, 1993 Sec. 102(e) Date Jun. 21, 1993 PCT Filed Dec. 19, 1991 PCT Pub. No. WO92/11234 PCT Pub. Date Jul. 9, 1992.Compounds of the formula I     <IMAGE>  (I)  in which R1 signifies an aryl, aralkyl or an aralkenyl group, the aryl radical of which can, in each case, be substituted one or more times by halogen, cyano, alkyl, trifluoromethyl, alkoxy, alkylthio, trifluoromethoxy, hydroxyl or carboxyl, m a whole number from 1 to 3, n a whole number from 1 to 5, R2 hydrogen, an alkyl, aralkyl or acyl group, Q a bond or an oxygen atom, R3 hydrogen or a lower alkyl radical which is possibly terminally substituted by carboxyl or by a hydroxyl group and R4 hydrogen, a lower alkyl group with 1-4 C-atoms, which is possibly terminally substituted by carboxyl or hydroxyl, a possibly substituted phenyl, heteroaryl, cycloalkyl or acyl group or a group    <IMAGE>   in which R5 represents a straight-chained or branched alkyl chain with 1-4 C-atoms which is possibly terminally substituted by carboxyl, alkoxycarbonyl, aminocarbonyl, hydroxyl, mercapto, alkylthio or imidazolyl and Y a carboxyl, an alkoxycarbonyl, aminocarbonyl or cyano, formyl, hydroxymethyl, aminomethyl or ortho ester group, whereby R3 and R4 can also be component of a 5- or 6-membered saturated or unsaturated possibly substituted heterocycle with 1-4 heteroatoms which can be annellated with further ring compounds via one or more bonds, as well as their salts, esters and amides, processes for their preparation and medicaments with thromboxane-antagonistic action which contain these compounds.
Patent IL-101599-A0 (IL)
Title: Substituted 3-(pyridinylamino)-indoles and benzo(b)thiophenes,a process for their preparation and their use as medicaments
IPC: A61K31/44
Filed: 1992-04-15
Abstract: The present invention relates to compounds of the formula I <CHEM>  where   R1   is hydrogen, loweralkyl, loweralkenyl, loweralkynyl, arylloweralkyl, aminoloweralkyl, loweralkylaminoloweralkyl, formyl, loweralkylcarbonyl, aminoloweralkylcarbonyl or loweralkoxycarbonyl;  the group -X-Y= is <CHEM>  R2 and R3 being independently hydrogen or loweralkyl; W   is hydrogen, halogen, hydroxy, loweralkoxy, arylloweralkoxy or <CHEM> where R4 is hydrogen, loweralkyl or arylloweralkyl; R5 is loweralkyl or arylloweralkyl; or alternatively the group <CHEM>  as a whole is <CHEM>  , R6 being hydrogen, loweralkyl, aryl or arylloweralkyl; and Z   is hydrogen, halogen, loweralkyl, nitro or amino; which are useful for alleviating various memory dysfunctions such as Alzheimer's disease, as modulators of neurotransmitter functions such as serotonergic and adrenergic, and as such are useful as antidepressants, anxiolytics, atypical antipsychotics, antiemetics, and for the treatment of personality disorders such as obsessive compulsive disorders.
Patent IL-120007-A0 (IL)
Title: Compositions for eliminating human and animal excretement smells and a method for use therein
IPC: A61L9/01
Filed: 1997-01-14
Abstract: The present invention related to compositions (deodorizing or not) for human and animal excrement, especially pest and livestock, comprised of acidic agents and water soluble polymers, wherein the acidic agents are base neutralizers for the ammonia and indolic amines in the excrement and the water soluble polymers are barrier forming agents for the vapor of the offensive odor producing compounds in the excrement and for slowing down the air oxidative and enzymatic nitrification of the excrement ammonia and organic nitrogen thus dispersing the attenuating nitrate concentrations in the environment. The present invention further relates to a method of applying said compositions to excrement. Said compositions may be applied to excrement in liquid form by mixing the liquid composition together with the excrement, or in the form of a spray, by spraying the composition directly onto the excrement.
Patent IL-125925-A0 (IL)
Title: Isoquinolines useful as analgesics
IPC: C07D217/14
Filed: 1997-02-25
Abstract: PCT No. PCT/SE97/00315 Sec. 371 Date Oct. 6, 1997 Sec. 102(e) Date Oct. 6, 1997 PCT Filed Feb. 25, 1997 PCT Pub. No. WO97/31940 PCT Pub. Date Sep. 4, 1997The present invention is directed to compounds that act as analgesics and that have the structure of formula (I): wherein; Z is wherein, n is 1 or 2, and R0 is C6-12 aryl or C7-8 aralkyl; or R1 is selected from the group consisting of hydrogen; -NH-C1-6 alkyl; C1-6 alkyl; C6-12 aryl; C7-18 aralkyl; arginyl; and R30NHC(=NH)-, wherein R30 is hydrogen, C6-12 aryl, C7-18 aralkyl, or C1-6 alkyl; R2 is hydrogen; C1-6 alkyl; or OH; R3 is C6-12 aryl; C7-18 aralkyl; -CH2-C6H2R8R9;or -CH2-OHC6HR8R9, wherein each of R8 and R9 is independently, or hydrogen; R4 C6-12 aryl; C7-18 aralkyl; C1-12 alkyl; or a substituted or unsubstituted cyclohexyl; R5 is C1-6 alkyl; hydrogen; OH; halogen; SH; NO2; NH2; -NH-C1-6 alkyl; NH2C (=NH-; NH2C (=NH)-NH-; COOR31, wherein, R31 is hydrogen, or C1-6 alkyl; X is CH2NHC(O)-; CH2NHC(O)O; -C(O)NH-; or CH2NH-; and L is a C1-12 alkylene chain which can be substituted with at least one substituent selected from the group consisting of; a C3-C12 cycloalkyl containing at least one heteroatom; C1-6 alkyl; OR31; -NHC(O)R33; -OC(O)R34 -NHR35 wherein; and NR6R7; with the proviso that when R5 is hydrogen, Z is and X is -C(O)NH-, or -CH2NH-, then L is a C1-12 alkyl chain substituted with at least one substituent selected from the group consisting of; a C3-C12 cycloalkyl containing at least one heteroatom; C1-6 alkyl; OR31; SR32; -NHC(O)R33; -OC(O)R34, -NHR35; and NR6R7.
Patent IL-127874-A0 (IL)
Title: Truncated soluble tumor necrosis factor type-I and type-II receptors
IPC: A61K47/48
Filed: 1997-07-09
Abstract: Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.
Patent IL-128229-A0 (IL)
Title: Polypeptides having a single covalently bound n-terminal water-soluble polymer
IPC: A61K47/48
Filed: 1997-08-01
Abstract: This invention provides compositions consisting essentially of a polypeptide and a water-soluble polymer covalently bound thereto at the N-terminal ±-carbon atom via a hydrazone or reduced hydrazone bond, or an oxime or reduced oxime bond. This invention also provides methods of making the instant compositions, pharmaceutical compositions comprising same, and kits for use in preparing same.
Patent IL-133857-A0 (IL)
Title: Cube corner sheeting mold and method of making the same
IPC: B29D11/00
Filed: 1998-06-12
Abstract: Laminae suitable for use in molds for forming retroreflective cube corner elements and methods for making such laminae are disclosed. A representative lamina includes a first row of cube corner elements disposed in a first orientation and a second row of optically opposing cube corner elements disposed. The working surface of a lamina is provided with a plurality of cube corner elements formed by the optical surfaces defined by three groove sets. Opposing first and second groove sets are formed in the working surface of a lamina. The first groove set forms a plurality of structures having first and second optical surfaces disposed in mutually perpendicular planes that intersect along a reference edge. The second groove set forms a corresponding plurality of structures on the opposite side of the lamina. A third groove is formed in the working surface of the lamina along an axis substantially perpendicular to the axes of the grooves of the first and second groove sets. The surfaces of the third groove intersect the surfaces of the plurality of structures in substantially mutually perpendicular planes to define a plurality of cube corner elements. A plurality of such laminae can be assembled to form a mold useful in the manufacture of retroreflective products such as cube corner sheeting.
Patent IL-138417-A0 (IL)
Title: Immortalised cell lines derived from normal human skin tissues
IPC: A61L27/00
Filed: 1999-04-07
Abstract: An human keratinocyte cell line immortalized by means of at least one functional tumor gene of retroviral origin characterised in that it is (1) non-tumorigenic, (2) conserves the capacity for differentiation and for the expression of proteins and of enzymes expressed by normal differentiated keratinocytes even after an elevated number of passages in culture, and (3) forms a stratified and polarised epithelium having a stratum corneum ortho-keratinocyte, if cultivated in an organo-typical culture in a medium without serum and without a layer of nourishing cells. An improved process to immortalize human skin cells to obtain immortalized keratinocytes is characterised in that it comprises the following steps: (i) isolating a sample of human skin; (ii) preparing the sample of skin for in vitro culture; (iii) obtaining keratinocytes from this prepared sample of human skin and seeding in a growth medium without serum with said keratinocytes, on culture plates provided with a coating comprising fibronectin, collagen type I and SAB, which facilitate the fixation and the growth of cells; (iv) replacing the medium in a way sufficient to obtain an optimal confluent growth of cells in culture, continuously maintaining the coating of the plate; (v) transferring keratinocytes into a selection medium without serum on culture plates coated previously in a similar manner; (vi) infecting keratinocytes using functional tumor genes of at least two different retrovirus; (vii) transferring the resulting immortalized keratinocytes to a proliferation medium suitable for the proliferation of immortalised keratinocytes on culture plates coated in a similar way; (viii) transferring the resulting proliferated keratinocytes into a differentiation medium having a high content of calcium on culture boxes coated in a similar way. Use of keratinocytes for immunological, pharmacological, photo- and chemical-toxigological analyses of skin reaction and for expression of heterologous genes and for the construction of artificial skin.
Patent IL-148601-A0 (IL)
Title: Pesticidal macrolides
IPC: C12N1/20
Filed: 2000-09-13
Abstract: Macrolide compounds produced by culturing Saccharopolyspora species LW107129 (NRRL 30141) have insecticidal and acaricidal activity and are useful intermediates for preparing spinosyn analogs.
Patent IL-150637-A0 (IL)
Title: Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms
IPC: A23L1/305
Filed: 2001-07-24
Abstract: A composition is disclosed which can be used as a health food/dietary supplement or as a drug for the prevention and/or treatment of lipid metabolism disorders and allergic forms and for activating organic defences against infections and tumor processes, containing as its characterizing components isovaleryl L-carnitine and a polysaccharide selected from glucans and galactans.
Patent IL-151099-A0 (IL)
Title: Medical implant device for electrostimulation using discrete micro-electrodes
IPC: A61N1/36
Filed: 2001-02-01
Abstract: An improved medical implant device is provided which has a plurality of micro-electrodes. The use of a plurality of micro-electrodes allows a clinically effective electrical stimulation pathway to be selected once the implant is positioned within or adjacent to the tissue to be treated even if the implant is not optimally placed or located. Thus, in cases where the implant is not optimally placed, it is not necessary to remove the implant and then reposition it within or adjacent to the tissue to be treated, thereby reducing stress to the patient caused by additional surgery. Moreover, using the micro-electrodes of this invention, directional electrostimulation can be provided to the tissue to be treated. Implant devices with a plurality of micro-electrodes are provided which are especially adapted for use in reducing the frequency and/or severity of neurological tremors. Other implant devices having micro-electrodes are provided which are especially adapted for electrostimulation and/or electrical monitoring of endo-abdominal tissue or viscera.
Patent IL-151410-A0 (IL)
Title: Method for producing a photovoltaic thin film module
IPC: B32B38/00
Filed: 2001-03-05
Abstract: The invention relates to a method for producing a photovoltaic thin film module (1) which is provided with a thin film solar cell system (2) that is mounted on carrier materials (3) and is covered with a compound (4) on at least one side of the surface, whereby said compound consists of an encapsulating material and is provided with a sealing layer (5) on the side of the surface thereof, said side being arranged on the thin film solar cell system (2). According to a covering method, the encapsulating material (4) and the thin film solar cell system (2), together with the carrier (3), are guided along one another and are pressed under pressure and at an increased temperature in such a way that a weather-proof, photovoltaic thin film module in the form of a compound (1) is designed. According to a method that can be carried out easily, a photovoltaic thin film module that is resistant to UV light, water vapour and other effects of the weather is provided. The photovoltaic module can additionally be provided with flexible characteristics by selecting the carrier material in such a way that said material is configured in the form of plastic foils or plastic foil compounds for instance.
Patent IL-152487-A0 (IL)
Title: Backflow preventer apparatus and method with integration of shut-off valves
IPC: E03B7/07
Filed: 2001-04-27
Abstract: Backflow prevention is provided in connection with a device having one or more shut-off valves integrated with a double-check-valve backflow prevention device and/or housing. Preferably, a single housing encompasses two backflow preventer check valves, and upstream and downstream shut-off valves. Typically, end users cannot readily remove the shut-off valves (and/or their housing) from the backflow preventer check valves (and/or their housing). No flange or other connection between shut-off valves and backflow preventer check valves (and/or their housing) is required, reducing size, weight and labor requirements. The system can substantially reduce or eliminate potential for installation of double-check-valve backflow preventer devices without shut-off valves.
Patent IL-154252-A0 (IL)
Title: Method and device for testing the operativeness of printed circuit boards
IPC: G01R31/02
Filed: 2001-08-01
Abstract: A process for testing circuit boards for serviceability is designed such that a flexible layer ( 2 ) that is initially impermeable to current is placed directly on at least one side of the circuit board ( 1 ), making contact, and it is dynamically connected to a current conductor ( 3 ), the layer ( 2 ) is then energized and then a current passage is partially created at the contact points that delimit the respective conductor path ( 5 ) that is to be tested, and then the flow of current in the conductor path ( 5 ) is measured using the current conductor ( 3 ).
Patent IL-158623-A0 (IL)
Title: Subcellular targeting of therapeutic proteins
IPC: A61K45/00
Filed: 2002-04-30
Abstract: Targeted therapeutics that localize to a specific subcellular compartment such as the lysosome are provided. The targeted therapeutics include a therapeutic agent and a targeting moiety that binds a receptor on an exterior surface of the cell, permitting proper subcellular localization of the targeted therapeutic upon internalization of the receptor. Nucleic acids, cells and methods relation to the practice of the invention are also provided.
Patent IL-175441-A0 (IL)
Title: Stimulateur cardiaque orthorythmique inotrope
IPC: A61N1/362
Filed: 2006-05-04
Abstract: The device has an electrocardiogram acquisition unit (2) that automatically acquires cardiac rhythm and permits to know the interval between two waves from cardiac cycle. A logical unit (3) continually determines the duration of an electric refractory period which follows the last wave from the cycle. An impulse generator sends a stimulation pulse without delay at the end of the refractory period.
Patent IL-178050-A0 (IL)
Title: Process and apparatus for stamping a pattern onto a coated frozen confection
Filed: 2006-09-12
Abstract: A process for stamping a pattern onto a coated frozen confection is provided, the process comprising the steps of: at least partially covering the frozen confection with a layer of coating; and bringing a stamping surface into contact with the coated frozen confection; characterised in that that the stamping surface is resiliently mounted on a support. An apparatus for stamping a pattern onto a coated frozen confection is also provided.
Patent IL-220547-A0 (IL)
Title: Combinations and modes of administration of therapeutic agents and combination therapy
IPC: A61K33/243
Filed: 2012-06-21
Abstract: Provided herein is a composition comprising nanoparticles comprising paclitaxel and an albumin for use in a method for the treatment of cancer in an individual, wherein the method further comprises administering an antimetabolite.